Paroxysmal sympathetic hyperactivity in brain damage (scientific review). Part 1

Paroxysmal sympathetic hyperactivity (PSH) is a separate form of fever of central origin and is a neurological syndrome characterized by simultaneous paroxysmal occurrence of hypertension, hyperpyrexia, tachycardia, tachypnea, increased sweating and dystonic posture due to sympathetic activation in...

Full description

Saved in:
Bibliographic Details
Main Authors: O.V. Kravets, V.A. Sedinkin, V.V. Yekhalov, Yu.O. Ploshchenko, O.O. Zozulya
Format: Article
Language:English
Published: Zaslavsky O.Yu. 2024-11-01
Series:Медицина неотложных состояний
Subjects:
Online Access:https://emergency.zaslavsky.com.ua/index.php/journal/article/view/1775
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841545064482865152
author O.V. Kravets
V.A. Sedinkin
V.V. Yekhalov
Yu.O. Ploshchenko
O.O. Zozulya
author_facet O.V. Kravets
V.A. Sedinkin
V.V. Yekhalov
Yu.O. Ploshchenko
O.O. Zozulya
author_sort O.V. Kravets
collection DOAJ
description Paroxysmal sympathetic hyperactivity (PSH) is a separate form of fever of central origin and is a neurological syndrome characterized by simultaneous paroxysmal occurrence of hypertension, hyperpyrexia, tachycardia, tachypnea, increased sweating and dystonic posture due to sympathetic activation in brain damage. PSH is a syndrome that can manifest itself in a wide range of clinical symptoms. Paroxysmal sympathetic hyperacti-vity is an example of a clinical correlate of central and autonomic nervous system dysfunction. Almost all cases of PSH are associated with craniocerebral trauma, hypoxia, and acute cerebrovascular accident. There is a disengagement theory and a model of the excitation-inhibition relationship of the PSH pathogenesis. In 2014, an expert consensus group proposed a PSH-assessment measure (PSH-AM), which can not only serve as a reliable diagnostic criterion but also stratify the severity of PSH. Assuming clinical evaluation as the current gold standard, PSH-AM has a sensiti- vity of 94 % when used retrospectively. In the treatment of patients with traumatic brain injury, PSH-AM can help avoid misdiagnosis, increase diagnostic efficiency, save time, and reduce economic costs. Hypodiagnosis of PSH can lead to an increase in mortality, disability, length of hospital stay and material costs, but timely diagnosis will allow optimizing treatment for PSH.
format Article
id doaj-art-8f12f2f329b142bf9e5968c4a92b256a
institution Kabale University
issn 2224-0586
2307-1230
language English
publishDate 2024-11-01
publisher Zaslavsky O.Yu.
record_format Article
series Медицина неотложных состояний
spelling doaj-art-8f12f2f329b142bf9e5968c4a92b256a2025-01-12T11:41:05ZengZaslavsky O.Yu.Медицина неотложных состояний2224-05862307-12302024-11-0120756857610.22141/2224-0586.20.7.2024.17751775Paroxysmal sympathetic hyperactivity in brain damage (scientific review). Part 1O.V. Kravets0https://orcid.org/0000-0003-1340-3290V.A. Sedinkin1https://orcid.org/0000-0002-8894-1598V.V. Yekhalov2https://orcid.org/0000-0001-5373-3820Yu.O. Ploshchenko3https://orcid.org/0000-0003-0538-0164O.O. Zozulya4https://orcid.org/0000-0003-1024-5987Dnipro State Medical University, Dnipro, UkraineDnipro State Medical University, Dnipro, UkraineDnipro State Medical University, Dnipro, UkraineDnipro State Medical University, Dnipro, UkraineDnipro State Medical University, Dnipro, UkraineParoxysmal sympathetic hyperactivity (PSH) is a separate form of fever of central origin and is a neurological syndrome characterized by simultaneous paroxysmal occurrence of hypertension, hyperpyrexia, tachycardia, tachypnea, increased sweating and dystonic posture due to sympathetic activation in brain damage. PSH is a syndrome that can manifest itself in a wide range of clinical symptoms. Paroxysmal sympathetic hyperacti-vity is an example of a clinical correlate of central and autonomic nervous system dysfunction. Almost all cases of PSH are associated with craniocerebral trauma, hypoxia, and acute cerebrovascular accident. There is a disengagement theory and a model of the excitation-inhibition relationship of the PSH pathogenesis. In 2014, an expert consensus group proposed a PSH-assessment measure (PSH-AM), which can not only serve as a reliable diagnostic criterion but also stratify the severity of PSH. Assuming clinical evaluation as the current gold standard, PSH-AM has a sensiti- vity of 94 % when used retrospectively. In the treatment of patients with traumatic brain injury, PSH-AM can help avoid misdiagnosis, increase diagnostic efficiency, save time, and reduce economic costs. Hypodiagnosis of PSH can lead to an increase in mortality, disability, length of hospital stay and material costs, but timely diagnosis will allow optimizing treatment for PSH.https://emergency.zaslavsky.com.ua/index.php/journal/article/view/1775examinationbrain damageparoxysmal sympathetic hyperactivitypathophysiologyclinical picturediagnosis
spellingShingle O.V. Kravets
V.A. Sedinkin
V.V. Yekhalov
Yu.O. Ploshchenko
O.O. Zozulya
Paroxysmal sympathetic hyperactivity in brain damage (scientific review). Part 1
Медицина неотложных состояний
examination
brain damage
paroxysmal sympathetic hyperactivity
pathophysiology
clinical picture
diagnosis
title Paroxysmal sympathetic hyperactivity in brain damage (scientific review). Part 1
title_full Paroxysmal sympathetic hyperactivity in brain damage (scientific review). Part 1
title_fullStr Paroxysmal sympathetic hyperactivity in brain damage (scientific review). Part 1
title_full_unstemmed Paroxysmal sympathetic hyperactivity in brain damage (scientific review). Part 1
title_short Paroxysmal sympathetic hyperactivity in brain damage (scientific review). Part 1
title_sort paroxysmal sympathetic hyperactivity in brain damage scientific review part 1
topic examination
brain damage
paroxysmal sympathetic hyperactivity
pathophysiology
clinical picture
diagnosis
url https://emergency.zaslavsky.com.ua/index.php/journal/article/view/1775
work_keys_str_mv AT ovkravets paroxysmalsympathetichyperactivityinbraindamagescientificreviewpart1
AT vasedinkin paroxysmalsympathetichyperactivityinbraindamagescientificreviewpart1
AT vvyekhalov paroxysmalsympathetichyperactivityinbraindamagescientificreviewpart1
AT yuoploshchenko paroxysmalsympathetichyperactivityinbraindamagescientificreviewpart1
AT oozozulya paroxysmalsympathetichyperactivityinbraindamagescientificreviewpart1